A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
Ichiro Ikushima1, Kazuchika Yonenaga1, Hironao Iwakiri2, Hideki Nagoshi2, Haruhito Kumagai2, Yasuyuki Yamashita31Department of Radiology, 2Department of Cardiology, Miyakonojo Medical Association Hospital, Miyakonojo, Japan; 3Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto Uni...
Saved in:
Main Authors: | Ikushima I, Yonenaga K, Iwakiri H, Nagoshi H, Kumagai H, Yamashita Y |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/d7edb3373e7d4400aadbafec2ac11df3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
by: Litsky J, et al.
Published: (2014) -
Carotid artery stenting: current and emerging options
by: Morr S, et al.
Published: (2014) -
Updates on the use of ureteral stents: focus on the Resonance® stent
by: Thomas MT Turk, et al.
Published: (2010) -
Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010) -
Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent
by: Jonathan Bridges, et al.
Published: (2008)